statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.023
SG - Singapore	195
CN - Cina	105
IT - Italia	90
SE - Svezia	74
GB - Regno Unito	72
HK - Hong Kong	57
BR - Brasile	48
DE - Germania	48
RU - Federazione Russa	30
VN - Vietnam	28
FI - Finlandia	25
FR - Francia	17
ID - Indonesia	12
BG - Bulgaria	9
CA - Canada	9
KR - Corea	9
NL - Olanda	9
SI - Slovenia	8
JP - Giappone	7
AR - Argentina	6
IN - India	6
PL - Polonia	6
AT - Austria	4
IE - Irlanda	4
MX - Messico	4
BD - Bangladesh	3
IR - Iran	3
LT - Lituania	3
MY - Malesia	3
TR - Turchia	3
AZ - Azerbaigian	2
CL - Cile	2
CO - Colombia	2
ES - Italia	2
HR - Croazia	2
JO - Giordania	2
LU - Lussemburgo	2
MC - Monaco	2
SK - Slovacchia (Repubblica Slovacca)	2
ZA - Sudafrica	2
BE - Belgio	1
BO - Bolivia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
IQ - Iraq	1
KE - Kenya	1
KH - Cambogia	1
NP - Nepal	1
RO - Romania	1
SA - Arabia Saudita	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.953

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	335
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies	275
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients	221
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART	217
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort	216
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering	209
Evaluation of HIV transmission clusters among natives and foreigners living in Italy	188
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016	167
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus	147
Totale	1.975

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	190	0	0	0	0	0	56	15	38	20	14	30	17
2021/2022	238	31	16	15	11	14	16	12	15	24	14	47	23
2022/2023	283	37	41	21	30	30	28	15	22	26	0	17	16
2023/2024	137	6	8	14	16	28	14	11	15	2	1	7	15
2024/2025	466	15	5	6	39	77	72	41	21	49	23	45	73
2025/2026	440	64	32	50	94	177	23	0	0	0	0	0	0
Totale													1.975